
JBS N.V.
100
Recent news highlights sustained investor interest in JBS, with multiple reports of noteworthy ETF inflows and positive analyst coverage.
- Multiple reports in early 2026 highlight significant ETF inflows involving JBS, indicating strong investor interest [N1][N2][N3][N4].
- JBS's stock has been noted for outperformance relative to consumer staples peers in early 2026 [N5].
- JP Morgan maintained an overweight recommendation on JBS as of October 2025 [N8].
JBS N.V. is the world's largest protein company by net revenue, operating a global platform that prepares and delivers a wide range of protein products including beef, poultry, pork, lamb, fish, and eggs. The company has significant processing capacities across multiple continents, including the largest global capacities in beef and poultry production. Its products are marketed under numerous well-known brands across North America, Brazil, Australia, and Europe. JBS operates through seven reportable segments and serves over 330,000 customers worldwide. The company generates the majority of its revenue domestically in countries where it operates facilities, with a substantial portion from exports, particularly to Asia, Africa, and the Middle East. JBS has made strategic investments to expand its production capabilities and diversify geographically, including new facilities in the US and a multiprotein platform in Oman. The company maintains a strong liquidity position and a well-staggered debt maturity profile, supported by cash flows from operations and credit facilities.
JBS N.V. is a leading global protein and food company with diversified operations across beef, poultry, pork, lamb, fish, and eggs. The company reported net revenue of $86.2 billion and net income of $2.2 billion for the year ended December 31, 2025. It operates seven business segments and sells products in approximately 197 countries. JBS maintains a strong liquidity position with $4.57 billion in cash and equivalents and a current ratio of 1.6 as of December 31, 2025. The company faces regulatory risks related to environmental compliance, anti-corruption laws, and political-economic conditions in Brazil. Recent news indicates sustained investor interest with multiple ETF inflows and positive analyst coverage. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
JBS's scale and diversified global operations position it to serve a broad customer base across multiple protein categories and geographies. Its strong liquidity and capital resources support ongoing investments in production capacity and product innovation. The company's ability to generate significant net revenue and net income demonstrates operational strength. Positive investor interest, as reflected in ETF inflows and analyst recommendations, underscores market confidence in its business model and growth initiatives.
JBS faces significant regulatory risks including environmental compliance, climate-related regulations, and anti-corruption laws, which may increase costs and operational complexity. Political and economic instability in Brazil, a key market, could adversely affect operations and financial results. The dual-class share structure concentrates voting power, potentially limiting shareholder influence. Market conditions such as commodity price volatility and changing consumer preferences towards plant-based proteins may impact demand for animal-based products. These factors could challenge the company's financial performance and reputation.
JBS's competitive moat is anchored in its scale as the largest global protein producer with leading capacities in beef, poultry, and pork processing. Its diversified geographic footprint and broad product portfolio across multiple protein types provide resilience and market reach. The company's extensive brand portfolio and established relationships with a large global customer base enhance its market position. Strategic investments in production facilities and expansion into new markets support its operational capabilities. However, the company faces regulatory and compliance risks that require ongoing management and investment.
• Regulatory and Environmental Compliance Risks: JBS is subject to extensive and increasingly stringent environmental and animal welfare regulations globally, which may increase costs and operational risks. Non-compliance could result in civil, criminal, and administrative penalties.
• Anti-Corruption and Legal Risks: The company operates under multiple anti-corruption laws including the U.S. FCPA, U.K. Bribery Act, and Brazil Clean Company Act. Violations could lead to severe penalties and reputational damage.
• Political and Economic Risks in Brazil: Brazil's political and economic environment, including government interventions and policy changes, may materially affect JBS's operations and financial condition.
• Market and Consumer Demand Risks: Growing consumer interest in plant-based proteins and concerns about health and environmental impacts of animal-based meat could negatively affect demand for JBS's products.
• Financial and Liquidity Risks: JBS carries significant indebtedness with $21.1 billion outstanding as of December 31, 2025. While liquidity is currently strong, economic or market disruptions could impact access to capital and debt servicing.
Business trends: Continued diversification across protein types and geographies, with strategic investments in production capacity and expansion into new markets.
Execution milestones: Completion of new production facilities in the US and Oman, maintaining strong liquidity and managing regulatory compliance.
Key risks: Regulatory compliance costs, anti-corruption legal risks, political and economic instability in Brazil, and shifting consumer preferences impacting demand.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- JBS N.V. is the largest protein company and one of the largest food companies globally by net revenue as of December 31, 2025, with net revenue of approximately $86.2 billion for the year ended 2025 [S1].
- The company recorded a net income of approximately $2.2 billion for the year ended December 31, 2025 [S1].
- JBS operates a diversified global platform preparing, packaging, and delivering fresh and frozen, value-added and branded beef, poultry, pork, fish, lamb, and egg products to over 330,000 customers worldwide in about 197 countries on six continents [S1].
- JBS is the #1 global beef producer by capacity, with operations in the US, Australia, Canada, and Brazil, processing over 78,000 heads of cattle daily [S1].
- It is also the #1 global poultry producer by capacity, with operations in the US, Brazil, UK, Mexico, Puerto Rico, and Europe, processing over 14 million chickens daily [S1].
- JBS is the #2 largest global pork producer by capacity, with operations in the US, Brazil, UK, Australia, and Europe, processing over 149,000 hogs daily [S1].
- The company is a leading lamb producer with operations in Australia and Europe, processing over 23,500 heads daily [S1].
- JBS is a leading regional fish producer in Australia with a processing capacity of approximately 200 tons daily [S1].
- It is a leading table eggs producer in Brazil, operating in six Brazilian states with an annual capacity of about 4 billion table eggs [S1].
- JBS markets its products under various national and regional brands across North America, Brazil, Australia, and Europe, including Swift, Just Bare, Pilgrim's Pride, 1855, Gold Kist Farms, Seara, Friboi, Moy Park, and others [S1].
- The company operates seven reportable business segments: Brazil, Seara, Beef North America, Pork USA, Pilgrim's Pride, Australia, and Miscellaneous [S1].
- In 2025, 74% of net revenue was from domestic sales in countries where JBS operates facilities, and 26% was from export sales, with Asia representing 50% of export sales, primarily China, Japan, and South Korea [S1].
- JBS's liquidity position as of December 31, 2025, included cash and cash equivalents of approximately $4.57 billion, current assets of about $18.44 billion, and current liabilities of about $11.54 billion, resulting in a current ratio of 1.6 and a cash ratio of 0.4 [S1].
- Total outstanding indebtedness as of December 31, 2025, was approximately $21.1 billion, with a well-staggered debt maturity profile and borrowing capacity under revolving credit facilities of about $3.53 billion [S1].
- JBS's principal cash requirements include raw material purchases, working capital, debt servicing, capital expenditures, strategic investments, dividends, and taxes [S1].
- The company has made strategic investments and capital expenditures in 2025 and 2026, including new production facilities in the US and a multiprotein production platform in Oman [S1].
- JBS is subject to extensive environmental, animal welfare, and climate-related regulations globally, which may increase costs and operational risks [S1].
- The company faces risks related to compliance with anti-corruption laws such as the U.S. Foreign Corrupt Practices Act, U.K. Bribery Act, and Brazil Clean Company Act, with potential civil and criminal penalties for violations [S1].
- Political and economic conditions in Brazil, including government interventions and policy changes, may materially affect JBS's operations and financial condition [S1].
- JBS has a dual-class share structure concentrating voting control with Class B shareholders, limiting influence of other shareholders [S1].
- Recent news highlights include multiple reports of noteworthy ETF inflows involving JBS, indicating investor interest [N1][N2][N3][N4].
- JP Morgan maintained an overweight recommendation on JBS as of October 2025 [N8].
- JBS's stock has been noted for outperformance relative to consumer staples peers in early 2026 [N5].
Generated 2026-03-25
- S1 | 2026-03-25 | 20-F
- S2 | 2026-02-17 | 6-K
- N1 | 2026-03-25 | www.nasdaq.com | Noteworthy ETF Inflows: EMXC, JBS, BVN, STNE | https://www.nasdaq.com/articles/noteworthy-etf-inflows-emxc-jbs-bvn-stne
- N2 | 2026-02-09 | www.nasdaq.com | IEMG, NU, XP, JBS: Large Inflows Detected at ETF | https://www.nasdaq.com/articles/iemg-nu-xp-jbs-large-inflows-detected-etf
- N3 | 2026-01-30 | www.nasdaq.com | EWZ, NU, XP, JBS: ETF Inflow Alert | https://www.nasdaq.com/articles/ewz-nu-xp-jbs-etf-inflow-alert
- N4 | 2026-01-22 | www.nasdaq.com | Noteworthy ETF Inflows: EWZ, XP, JBS, STNE | https://www.nasdaq.com/articles/noteworthy-etf-inflows-ewz-xp-jbs-stne
- N5 | 2026-01-15 | www.nasdaq.com | Is JBS N.V. (JBS) Stock Outpacing Its Consumer Staples Peers This Year? | https://www.nasdaq.com/articles/jbs-nv-jbs-stock-outpacing-its-consumer-staples-peers-year
- N6 | 2025-12-26 | www.nasdaq.com | Validea's Top Consumer Staples Stocks Based On Martin Zweig - 12/26/2025 | https://www.nasdaq.com/articles/valideas-top-consumer-staples-stocks-based-martin-zweig-12-26-2025
- N7 | 2025-12-08 | www.nasdaq.com | Monday's ETF with Unusual Volume: BRIE | https://www.nasdaq.com/articles/mondays-etf-unusual-volume-brie
- N8 | 2025-11-28 | www.nasdaq.com | Validea's Top Consumer Staples Stocks Based On Joel Greenblatt - 11/28/2025 | https://www.nasdaq.com/articles/valideas-top-consumer-staples-stocks-based-joel-greenblatt-11-28-2025
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


